The DOI matches its Crossref record.
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
Open accessAbstract
Hemolytic uremic syndrome (HUS) is a disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Recent studies have identified a factor H-associated form of HUS, caused by gene mutations that cluster in the C-terminal region of the complement regulator factor H. Here we report how three mutations (E1172Stop, R1210C, and R1215G; each of the latter two identified in three independent cases from different, unrelated families) affect protein function. All three mutations cause reduced binding to the central complement component C3b/C3d to heparin, as well as to endothelial cells. These defective features of the mutant factor H proteins explain progression of endothelial cell and microvascular damage in factor H-associated genetic HUS and indicate a protective role of factor H for tissue integrity during thrombus formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 40
- Kaplan, 1998, J. Am. Soc. Nephrol., 9, 1126, 10.1681/ASN.V961126 · DOI · Paper page
- Remuzzi, 1998, Kidney Int. Suppl., 66, S54
- Kaplan, 1978, N. Engl. J. Med., 298, 964, 10.1056/NEJM197804272981710 · DOI
- Thompson, 1981, Clin. Exp. Immunol., 46, 110
- 10.1086/302877 · doi:10.1086/302877
- Mathieson, 2002, Lancet., 359, 801, 10.1016/S0140-6736(02)07866-2 · doi:10.1016/s0140-6736(02)07866-2
- Caprioli, 2001, J. Am. Soc. Nephrol., 12, 297, 10.1681/ASN.V122297 · DOI · Paper page
- 10.1086/318201 · DOI · Paper page
- 10.1086/318203 · DOI · Paper page
- 10.1016/S0140-6736(01)06339-5 · doi:10.1016/s0140-6736(01)06339-5
- 10.1021/bi00270a026 · DOI
- 10.1084/jem.144.5.1147 · DOI · Paper page
- 10.1016/S0161-5890(99)00038-3 · DOI
- 10.1074/jbc.M001123200 · DOI · Paper page
- DiScipio, 1998, J. Immunol., 160, 4057
- Jokiranta, 2000, J. Biol. Chem., 275, 27657, 10.1074/jbc.M002903200 · DOI · Paper page
- Prodinger, 1998, Biochem. J., 331, 41, 10.1042/bj3310041 · DOI
- Blackmore, 1998, J. Immunol., 160, 3342
- 10.1074/jbc.272.40.25168 · DOI · Paper page
- 10.1016/S1567-5769(00)00047-3 · DOI
- 10.1093/ndt/14.5.1229 · doi:10.1093/ndt/14.5.1229
- Monnens, 1980, Clin. Nephrol., 13, 168
- Kaplan, 1975, N. Engl. J. Med., 292, 1090, 10.1056/NEJM197505222922102 · DOI · Paper page
- Noris, 1999, J. Am. Soc. Nephrol., 10, 281, 10.1681/ASN.V102281 · doi:10.1681/asn.v102281
- 10.1111/j.1523-1755.1998.00824.x · doi:10.1111/j.1523-1755.1998.00824.x · Paper page
- 10.1016/S1567-5769(00)00042-4 · DOI
- 10.1073/pnas.93.20.10996 · DOI · Paper page
- 10.1016/0378-1119(95)00360-I · doi:10.1016/0378-1119(95)00360-i
- Gordon, 1995, J. Immunol., 155, 348
- 10.1002/eji.1830261017 · DOI · Paper page
- Kuhn, 1995, J. Immunol., 155, 5663
- 10.1016/S0162-3109(99)00015-6 · DOI · Paper page
- 10.1006/jmbi.2001.5337 · DOI
- 10.1093/ndt/13.8.1921 · doi:10.1093/ndt/13.8.1921
- 10.1016/S1471-4906(01)01972-X · DOI
- Zoja, 2001, J. Nephrol., 4(Suppl.), S58
- Hindmarsh, 1998, J. Immunol., 160, 6128
- 10.1073/pnas.84.16.5873 · DOI
- Pangburn, 2002, J. Immunol., 169, 4702, 10.4049/jimmunol.169.9.4702 · DOI
- 10.1086/344515 · DOI · Paper page
Cited by
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Self-citationCaprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationThe Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Markiewski, M. M., & Lambris, J. D. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070166 · Cited by 722
Metadata
- Authors
- Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-04-15
- Volume
- 111
- Issue
- 8
- Pages
- 1181-1190
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1965972308
- Cited by
- 350
- References
- 0
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. https://app.cochat.ai/papers/10.1172/jci16651
- The paper
- Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003). Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. Journal of Clinical Investigation. https://doi.org/10.1172/jci16651
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.